secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2022-06-29T23:59:59+00:00
Accession:  0001193125-22-185142
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus CCO John Nosenzo to retire Oct 1; role not replaced
-------------------------------------------------------------

- John E. Nosenzo, Chief Commercial Officer, to retire effective October 1, 2022.
- Company will not replace CCO role; sales management responsibilities transition to three promoted direct reports.
- Transition plan agreed on June 27, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000119312522185142/0001193125-22-185142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000119312522185142/d360820d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-185142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer